# Changes in Intrathoracic Impedance During Sacubitril/Valsartan Treatment

> **NCT03359967** · — · UNKNOWN · sponsor: **Central Hospital, Izmir** · enrollment: 24 (estimated)

## Conditions studied

- Heart Failure With Reduced Ejection Fraction

## Interventions

- **DRUG:** Entresto tablet

## Key facts

- **NCT ID:** NCT03359967
- **Lead sponsor:** Central Hospital, Izmir
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-02-12
- **Primary completion:** 2018-06-29
- **Final completion:** 2018-08-31
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2017-12-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03359967

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03359967, "Changes in Intrathoracic Impedance During Sacubitril/Valsartan Treatment". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03359967. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*